3.22.1 html 207 363 1 false 97 0 false 11 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://aridispharma.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Condensed Consolidated Balance Sheets Sheet http://aridispharma.com/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://aridispharma.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Condensed Consolidated Statements of Operations Sheet http://aridispharma.com/role/StatementCondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficit) Sheet http://aridispharma.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit Consolidated Statements of Changes in Stockholders' Equity (Deficit) Statements 5 false false R6.htm 00400 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://aridispharma.com/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 10101 - Disclosure - Description of Business and Basis of Presentation Sheet http://aridispharma.com/role/DisclosureDescriptionOfBusinessAndBasisOfPresentation Description of Business and Basis of Presentation Notes 7 false false R8.htm 10201 - Disclosure - Summary of Significant Accounting Policies Sheet http://aridispharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 10301 - Disclosure - Fair Value Disclosure Sheet http://aridispharma.com/role/DisclosureFairValueDisclosure Fair Value Disclosure Notes 9 false false R10.htm 10401 - Disclosure - Balance Sheet Components Sheet http://aridispharma.com/role/DisclosureBalanceSheetComponents Balance Sheet Components Notes 10 false false R11.htm 10501 - Disclosure - Equity Method Investment Sheet http://aridispharma.com/role/DisclosureEquityMethodInvestment Equity Method Investment Notes 11 false false R12.htm 10601 - Disclosure - Collaboration, Development and License Agreements Sheet http://aridispharma.com/role/DisclosureCollaborationDevelopmentAndLicenseAgreements Collaboration, Development and License Agreements Notes 12 false false R13.htm 10701 - Disclosure - Notes Payable Notes http://aridispharma.com/role/DisclosureNotesPayable Notes Payable Notes 13 false false R14.htm 10801 - Disclosure - Warrants Sheet http://aridispharma.com/role/DisclosureWarrants Warrants Notes 14 false false R15.htm 10901 - Disclosure - Common Stock Sheet http://aridispharma.com/role/DisclosureCommonStock Common Stock Notes 15 false false R16.htm 11001 - Disclosure - Stock-Based Compensation Sheet http://aridispharma.com/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 16 false false R17.htm 11101 - Disclosure - Income Taxes Sheet http://aridispharma.com/role/DisclosureIncomeTaxes Income Taxes Notes 17 false false R18.htm 11201 - Disclosure - Related Parties Sheet http://aridispharma.com/role/DisclosureRelatedParties Related Parties Notes 18 false false R19.htm 11301 - Disclosure - Commitments and Contingencies Sheet http://aridispharma.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 19 false false R20.htm 11401 - Disclosure - Subsequent Events Sheet http://aridispharma.com/role/DisclosureSubsequentEvents Subsequent Events Notes 20 false false R21.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://aridispharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://aridispharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies 21 false false R22.htm 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://aridispharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://aridispharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies 22 false false R23.htm 30403 - Disclosure - Balance Sheet Components (Tables) Sheet http://aridispharma.com/role/DisclosureBalanceSheetComponentsTables Balance Sheet Components (Tables) Tables http://aridispharma.com/role/DisclosureBalanceSheetComponents 23 false false R24.htm 30903 - Disclosure - Common Stock (Tables) Sheet http://aridispharma.com/role/DisclosureCommonStockTables Common Stock (Tables) Tables http://aridispharma.com/role/DisclosureCommonStock 24 false false R25.htm 31003 - Disclosure - Stock-Based Compensation (Tables) Sheet http://aridispharma.com/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://aridispharma.com/role/DisclosureStockBasedCompensation 25 false false R26.htm 31103 - Disclosure - Income Taxes (Tables) Sheet http://aridispharma.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://aridispharma.com/role/DisclosureIncomeTaxes 26 false false R27.htm 31303 - Disclosure - Commitments and Contingencies (Tables) Sheet http://aridispharma.com/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://aridispharma.com/role/DisclosureCommitmentsAndContingencies 27 false false R28.htm 40101 - Disclosure - Description of Business and Basis of Presentation (Details) Sheet http://aridispharma.com/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationDetails Description of Business and Basis of Presentation (Details) Details http://aridispharma.com/role/DisclosureDescriptionOfBusinessAndBasisOfPresentation 28 false false R29.htm 40201 - Disclosure - Summary of Significant Accounting Policies - Concentrations (Details) Sheet http://aridispharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesConcentrationsDetails Summary of Significant Accounting Policies - Concentrations (Details) Details 29 false false R30.htm 40202 - Disclosure - Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://aridispharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) Details 30 false false R31.htm 40203 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable and Allowance for Doubtful Accounts (Details) Sheet http://aridispharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableAndAllowanceForDoubtfulAccountsDetails Summary of Significant Accounting Policies - Accounts Receivable and Allowance for Doubtful Accounts (Details) Details 31 false false R32.htm 40204 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment and Impairment of Long-Lived Assets (Details) Sheet http://aridispharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentAndImpairmentOfLongLivedAssetsDetails Summary of Significant Accounting Policies - Property and Equipment and Impairment of Long-Lived Assets (Details) Details 32 false false R33.htm 40205 - Disclosure - Summary of Significant Accounting Policies - Impairment of Long-Lived Assets (Details) Sheet http://aridispharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesImpairmentOfLongLivedAssetsDetails Summary of Significant Accounting Policies - Impairment of Long-Lived Assets (Details) Details 33 false false R34.htm 40206 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details) Sheet http://aridispharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails Summary of Significant Accounting Policies - Revenue Recognition (Details) Details 34 false false R35.htm 40207 - Disclosure - Summary of Significant Accounting Policies - Stock-Based Compensation (Details) Sheet http://aridispharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails Summary of Significant Accounting Policies - Stock-Based Compensation (Details) Details 35 false false R36.htm 40208 - Disclosure - Summary of Significant Accounting Policies - Loss Per Share (Details) Sheet http://aridispharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesLossPerShareDetails Summary of Significant Accounting Policies - Loss Per Share (Details) Details 36 false false R37.htm 40401 - Disclosure - Balance Sheet Components - Property and Equipment, net (Details) Sheet http://aridispharma.com/role/DisclosureBalanceSheetComponentsPropertyAndEquipmentNetDetails Balance Sheet Components - Property and Equipment, net (Details) Details 37 false false R38.htm 40402 - Disclosure - Balance Sheet Components - Intangible Assets, net (Details) Sheet http://aridispharma.com/role/DisclosureBalanceSheetComponentsIntangibleAssetsNetDetails Balance Sheet Components - Intangible Assets, net (Details) Details 38 false false R39.htm 40403 - Disclosure - Balance Sheet Components - Intangible Assets, Net- Amortization expense (Details) Sheet http://aridispharma.com/role/DisclosureBalanceSheetComponentsIntangibleAssetsNetAmortizationExpenseDetails Balance Sheet Components - Intangible Assets, Net- Amortization expense (Details) Details 39 false false R40.htm 40404 - Disclosure - Balance Sheet Components - Intangible Assets, Net - Licenses (Details) Sheet http://aridispharma.com/role/DisclosureBalanceSheetComponentsIntangibleAssetsNetLicensesDetails Balance Sheet Components - Intangible Assets, Net - Licenses (Details) Details 40 false false R41.htm 40405 - Disclosure - Balance Sheet Components - Licenses (Details) Sheet http://aridispharma.com/role/DisclosureBalanceSheetComponentsLicensesDetails Balance Sheet Components - Licenses (Details) Details 41 false false R42.htm 40406 - Disclosure - Balance Sheet Components - Medimmune Limited License Agreement (Details) Sheet http://aridispharma.com/role/DisclosureBalanceSheetComponentsMedimmuneLimitedLicenseAgreementDetails Balance Sheet Components - Medimmune Limited License Agreement (Details) Details 42 false false R43.htm 40407 - Disclosure - Balance Sheet Components - Accrued Liabilities (Details) Sheet http://aridispharma.com/role/DisclosureBalanceSheetComponentsAccruedLiabilitiesDetails Balance Sheet Components - Accrued Liabilities (Details) Details 43 false false R44.htm 40408 - Disclosure - Balance Sheet Components - Broad Institute of MIT and Harvard (Details) Sheet http://aridispharma.com/role/DisclosureBalanceSheetComponentsBroadInstituteOfMitAndHarvardDetails Balance Sheet Components - Broad Institute of MIT and Harvard (Details) Details 44 false false R45.htm 40501 - Disclosure - Equity Method Investment (Details) Sheet http://aridispharma.com/role/DisclosureEquityMethodInvestmentDetails Equity Method Investment (Details) Details http://aridispharma.com/role/DisclosureEquityMethodInvestment 45 false false R46.htm 40601 - Disclosure - Collaboration, Development and License Agreements - Cystic Fibrosis Foundation Development Agreement (Details) Sheet http://aridispharma.com/role/DisclosureCollaborationDevelopmentAndLicenseAgreementsCysticFibrosisFoundationDevelopmentAgreementDetails Collaboration, Development and License Agreements - Cystic Fibrosis Foundation Development Agreement (Details) Details 46 false false R47.htm 40602 - Disclosure - Collaboration, Development and License Agreements - Gates Foundation Grant (Details) Sheet http://aridispharma.com/role/DisclosureCollaborationDevelopmentAndLicenseAgreementsGatesFoundationGrantDetails Collaboration, Development and License Agreements - Gates Foundation Grant (Details) Details 47 false false R48.htm 40603 - Disclosure - Collaboration, Development and License Agreements - Serum License Agreement (Details) Sheet http://aridispharma.com/role/DisclosureCollaborationDevelopmentAndLicenseAgreementsSerumLicenseAgreementDetails Collaboration, Development and License Agreements - Serum License Agreement (Details) Details 48 false false R49.htm 40701 - Disclosure - Notes Payable - Note Purchase Agreement and Insurance Financing (Details) Notes http://aridispharma.com/role/DisclosureNotesPayableNotePurchaseAgreementAndInsuranceFinancingDetails Notes Payable - Note Purchase Agreement and Insurance Financing (Details) Details 49 false false R50.htm 40702 - Disclosure - Notes Payable - Paycheck Protection Program Loan (Details) Notes http://aridispharma.com/role/DisclosureNotesPayablePaycheckProtectionProgramLoanDetails Notes Payable - Paycheck Protection Program Loan (Details) Details 50 false false R51.htm 40801 - Disclosure - Warrants - Common Stock Warrant Expense (Details) Sheet http://aridispharma.com/role/DisclosureWarrantsCommonStockWarrantExpenseDetails Warrants - Common Stock Warrant Expense (Details) Details 51 false false R52.htm 40802 - Disclosure - Warrants - Warrants Issued in Registered Direct Offering (Details) Sheet http://aridispharma.com/role/DisclosureWarrantsWarrantsIssuedInRegisteredDirectOfferingDetails Warrants - Warrants Issued in Registered Direct Offering (Details) Details 52 false false R53.htm 40901 - Disclosure - Common Stock (Details) Sheet http://aridispharma.com/role/DisclosureCommonStockDetails Common Stock (Details) Details http://aridispharma.com/role/DisclosureCommonStockTables 53 false false R54.htm 40902 - Disclosure - Common Stock - March 2021 Securities Purchase Agreement (Details) Sheet http://aridispharma.com/role/DisclosureCommonStockMarch2021SecuritiesPurchaseAgreementDetails Common Stock - March 2021 Securities Purchase Agreement (Details) Details 54 false false R55.htm 40903 - Disclosure - Common Stock - MedImmune Limited License Agreement (Details) Sheet http://aridispharma.com/role/DisclosureCommonStockMedimmuneLimitedLicenseAgreementDetails Common Stock - MedImmune Limited License Agreement (Details) Details 55 false false R56.htm 40904 - Disclosure - Common Stock - August 2021 Securities Purchase Agreement (Details) Sheet http://aridispharma.com/role/DisclosureCommonStockAugust2021SecuritiesPurchaseAgreementDetails Common Stock - August 2021 Securities Purchase Agreement (Details) Details 56 false false R57.htm 41001 - Disclosure - Stock-Based Compensation - Status of options (Details) Sheet http://aridispharma.com/role/DisclosureStockBasedCompensationStatusOfOptionsDetails Stock-Based Compensation - Status of options (Details) Details 57 false false R58.htm 41002 - Disclosure - Stock-Based Compensation - Stock option activity (Details) Sheet http://aridispharma.com/role/DisclosureStockBasedCompensationStockOptionActivityDetails Stock-Based Compensation - Stock option activity (Details) Details 58 false false R59.htm 41003 - Disclosure - Stock-Based Compensation - Assumptions (Details) Sheet http://aridispharma.com/role/DisclosureStockBasedCompensationAssumptionsDetails Stock-Based Compensation - Assumptions (Details) Details 59 false false R60.htm 41004 - Disclosure - Stock-Based Compensation - Expenses (Details) Sheet http://aridispharma.com/role/DisclosureStockBasedCompensationExpensesDetails Stock-Based Compensation - Expenses (Details) Details 60 false false R61.htm 41005 - Disclosure - Stock-Based Compensation - Additional information (Details) Sheet http://aridispharma.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails Stock-Based Compensation - Additional information (Details) Details 61 false false R62.htm 41101 - Disclosure - Income Taxes - Effective income tax rate reconciliation, Amount (Details) Sheet http://aridispharma.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationAmountDetails Income Taxes - Effective income tax rate reconciliation, Amount (Details) Details 62 false false R63.htm 41102 - Disclosure - Income Taxes - Components of deferred tax assets (liabilities) (Details) Sheet http://aridispharma.com/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails Income Taxes - Components of deferred tax assets (liabilities) (Details) Details 63 false false R64.htm 41103 - Disclosure - Income Taxes - Uncertain tax positions (Details) Sheet http://aridispharma.com/role/DisclosureIncomeTaxesUncertainTaxPositionsDetails Income Taxes - Uncertain tax positions (Details) Details 64 false false R65.htm 41104 - Disclosure - Income Taxes - Tax Cuts and Jobs Act of 2017 (Details) Sheet http://aridispharma.com/role/DisclosureIncomeTaxesTaxCutsAndJobsActOf2017Details Income Taxes - Tax Cuts and Jobs Act of 2017 (Details) Details 65 false false R66.htm 41105 - Disclosure - Income Taxes - Net operating loss carryforwards and Tax credit carryforwards (Details) Sheet http://aridispharma.com/role/DisclosureIncomeTaxesNetOperatingLossCarryforwardsAndTaxCreditCarryforwardsDetails Income Taxes - Net operating loss carryforwards and Tax credit carryforwards (Details) Details 66 false false R67.htm 41201 - Disclosure - Related Parties (Details) Sheet http://aridispharma.com/role/DisclosureRelatedPartiesDetails Related Parties (Details) Details http://aridispharma.com/role/DisclosureRelatedParties 67 false false R68.htm 41301 - Disclosure - Commitments and Contingencies - Facility lease - (Details) Sheet http://aridispharma.com/role/DisclosureCommitmentsAndContingenciesFacilityLeaseDetails Commitments and Contingencies - Facility lease - (Details) Details 68 false false R69.htm 41302 - Disclosure - Commitments and Contingencies - Future minimum lease payments (Details) Sheet http://aridispharma.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails Commitments and Contingencies - Future minimum lease payments (Details) Details 69 false false R70.htm 41303 - Disclosure - Commitments and Contingencies - Leases and Contingencies (Details) Sheet http://aridispharma.com/role/DisclosureCommitmentsAndContingenciesLeasesAndContingenciesDetails Commitments and Contingencies - Leases and Contingencies (Details) Details 70 false false R71.htm 41304 - Disclosure - Commitments and Contingencies - Cystic Fibrosis Foundation Agreement and Joint Venture Agreement (Details) Sheet http://aridispharma.com/role/DisclosureCommitmentsAndContingenciesCysticFibrosisFoundationAgreementAndJointVentureAgreementDetails Commitments and Contingencies - Cystic Fibrosis Foundation Agreement and Joint Venture Agreement (Details) Details 71 false false R72.htm 41305 - Disclosure - Commitments and Contingencies - Kermode Agreement (Details) Sheet http://aridispharma.com/role/DisclosureCommitmentsAndContingenciesKermodeAgreementDetails Commitments and Contingencies - Kermode Agreement (Details) Details 72 false false R73.htm 41306 - Disclosure - Commitments and Contingencies - Medimmune Limited License Agreement (Details) Sheet http://aridispharma.com/role/DisclosureCommitmentsAndContingenciesMedimmuneLimitedLicenseAgreementDetails Commitments and Contingencies - Medimmune Limited License Agreement (Details) Details 73 false false R74.htm 41401 - Disclosure - Subsequent Events (Details) Sheet http://aridispharma.com/role/DisclosureSubsequentEventsDetails Subsequent Events (Details) Details http://aridispharma.com/role/DisclosureSubsequentEvents 74 false false All Reports Book All Reports ards-20220330x10k.htm ards-20220330.xsd ards-20220330_cal.xml ards-20220330_def.xml ards-20220330_lab.xml ards-20220330_pre.xml ards-20220330xex21d1.htm ards-20220330xex23d1.htm ards-20220330xex31d1.htm ards-20220330xex31d2.htm ards-20220330xex32d1.htm ards-20220330xex32d2.htm ards-20220330x10k001.jpg ards-20220330x10k002.jpg ards-20220330x10k003.jpg ards-20220330x10k004.jpg ards-20220330x10k005.jpg ards-20220330x10k006.jpg ards-20220330x10k007.jpg ards-20220330x10k008.jpg ards-20220330x10k009.jpg ards-20220330x10k010.jpg ards-20220330x10k012.jpg ards-20220330x10k013.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true